Emily Randall, the congresswoman representing Washington's 6th congressional district, has recently sold stocks in a range of companies, according to a congressional trade report. The transactions ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

Law), Emily Hickman (first year, HAPP). The LINAS team got together just before the Christmas break for a very vibrant afternoon of food, fun and technical discussions. The event started off with ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Abbott Laboratories wasn’t one of them. The 10 stocks that ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week. The earnings season is in full flow ...